For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of LifeStance Health Group Inc (NASDAQ: LFST) closed at $6.41 in the last session, down -1.38% from day before closing price of $6.5. In other words, the price has decreased by -$1.38 from its previous closing price. On the day, 1.32 million shares were traded. LFST stock price reached its highest trading level at $6.515 during the session, while it also had its lowest trading level at $6.3601.
Ratios:
We take a closer look at LFST’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.89. For the most recent quarter (mrq), Quick Ratio is recorded 1.58 and its Current Ratio is at 1.58. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.28.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on November 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $8. On July 25, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $8. UBS Upgraded its Neutral to Buy on May 27, 2025, while the target price for the stock was maintained at $8.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 21 ’25 when Miller Lisa K sold 57,240 shares for $6.43 per share. The transaction valued at 368,053 led to the insider holds 261,292 shares of the business.
Miller Lisa K bought 57,240 shares of LFST for $368,143 on Nov 21 ’25. On Aug 18 ’25, another insider, Silversmith Partners I GP, LLC, who serves as the Member of 10% Group of the company, sold 3,592,357 shares for $5.07 each. As a result, the insider received 18,213,250 and left with 14,324,197 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 2493491712 and an Enterprise Value of 2763230720. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.82 while its Price-to-Book (P/B) ratio in mrq is 1.67. Its current Enterprise Value per Revenue stands at 2.021 whereas that against EBITDA is 42.676.
Stock Price History:
The Beta on a monthly basis for LFST is 1.12, which has changed by -0.12868631 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, LFST has reached a high of $8.30, while it has fallen to a 52-week low of $3.74. The 50-Day Moving Average of the stock is 14.20%, while the 200-Day Moving Average is calculated to be 11.05%.
Shares Statistics:
According to the various share statistics, LFST traded on average about 1.96M shares per day over the past 3-months and 1976240 shares per day over the past 10 days. A total of 389.00M shares are outstanding, with a floating share count of 159.69M. Insiders hold about 58.95% of the company’s shares, while institutions hold 40.27% stake in the company. Shares short for LFST as of 1763078400 were 6377649 with a Short Ratio of 3.26, compared to 1760486400 on 6947769. Therefore, it implies a Short% of Shares Outstanding of 6377649 and a Short% of Float of 7.39.
Earnings Estimates
At present, 2.0 analysts are actively evaluating the performance of LifeStance Health Group Inc (LFST) in the stock market.The consensus estimate for the next quarter is $0.05, with high estimates of $0.05 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.21 and $0.2 for the fiscal current year, implying an average EPS of $0.21. EPS for the following year is $0.25, with 2.0 analysts recommending between $0.27 and $0.23.
Revenue Estimates
According to 8 analysts,. The current quarter’s revenue is expected to be $378.05M. It ranges from a high estimate of $383.57M to a low estimate of $374.3M. As of. The current estimate, LifeStance Health Group Inc’s year-ago sales were $325.5MFor the next quarter, 8 analysts are estimating revenue of $381.48M. There is a high estimate of $389.86M for the next quarter, whereas the lowest estimate is $369.93M.
A total of 9 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $1.43B, while the lowest revenue estimate was $1.42B, resulting in an average revenue estimate of $1.42B. In the same quarter a year ago, actual revenue was $1.25BBased on 9 analysts’ estimates, the company’s revenue will be $1.62B in the next fiscal year. The high estimate is $1.64B and the low estimate is $1.6B.
